Dana-Farber Cancer Institute/Harvard University Medical Center

Boston, Massachusetts 02215

Use our guide to learn which trials are right for you!

We've found
1 trials
at this facility
Oncology Clinical Trial
Combination Margetuximab and Pembrolizumab for Advanced, Metastatic HER2(+) Gastric or Gastroesophageal Junction Cancer
Status: Enrolling, Phase I, II
Updated: 7/25/2017
Dana-Farber Cancer Institute/Harvard University Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials